Global Topical Drugs CDMO Market Growth (Status and Outlook) 2025-2031
Description
The global Topical Drugs CDMO market size is predicted to grow from US$ 5067 million in 2025 to US$ 8223 million in 2031; it is expected to grow at a CAGR of 8.4% from 2025 to 2031.
A Topical Drugs CDMO (Contract Development and Manufacturing Organization) is a specialized company that provides end-to-end services for the development, formulation, manufacturing, and packaging of topical drugs on behalf of pharmaceutical companies. Topical drugs are medications applied directly to the skin, mucous membranes, or other external surfaces (e.g., creams, gels, ointments, lotions, patches, sprays, and foams). These drugs are used to treat a wide range of conditions, including skin disorders, infections, pain, and inflammation.
United States market for Topical Drugs CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Topical Drugs CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Topical Drugs CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Topical Drugs CDMO players cover Cambrex Corporation, Bora Pharmaceutical CDMO, Piramal Pharma Solutions, Contract Pharmaceuticals Limited, Lubrizol Life Science, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Topical Drugs CDMO Industry Forecast” looks at past sales and reviews total world Topical Drugs CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Topical Drugs CDMO sales for 2025 through 2031. With Topical Drugs CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Drugs CDMO industry.
This Insight Report provides a comprehensive analysis of the global Topical Drugs CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Topical Drugs CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical Drugs CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Drugs CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Drugs CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Drugs CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Contract Development
Contract Manufacturing
Segmentation by Application:
Liquid Formulations
Semi-Solid Formulations
Solid Formulations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cambrex Corporation
Bora Pharmaceutical CDMO
Piramal Pharma Solutions
Contract Pharmaceuticals Limited
Lubrizol Life Science
Ascendia Pharmaceuticals
PCI Pharma Services
Pierre Fabre Group
DPT Laboratories LTD.
MedPharm Ltd.
Please note: The report will take approximately 2 business days to prepare and deliver.
A Topical Drugs CDMO (Contract Development and Manufacturing Organization) is a specialized company that provides end-to-end services for the development, formulation, manufacturing, and packaging of topical drugs on behalf of pharmaceutical companies. Topical drugs are medications applied directly to the skin, mucous membranes, or other external surfaces (e.g., creams, gels, ointments, lotions, patches, sprays, and foams). These drugs are used to treat a wide range of conditions, including skin disorders, infections, pain, and inflammation.
United States market for Topical Drugs CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Topical Drugs CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Topical Drugs CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Topical Drugs CDMO players cover Cambrex Corporation, Bora Pharmaceutical CDMO, Piramal Pharma Solutions, Contract Pharmaceuticals Limited, Lubrizol Life Science, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Topical Drugs CDMO Industry Forecast” looks at past sales and reviews total world Topical Drugs CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Topical Drugs CDMO sales for 2025 through 2031. With Topical Drugs CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Drugs CDMO industry.
This Insight Report provides a comprehensive analysis of the global Topical Drugs CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Topical Drugs CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical Drugs CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Drugs CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Drugs CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Drugs CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Contract Development
Contract Manufacturing
Segmentation by Application:
Liquid Formulations
Semi-Solid Formulations
Solid Formulations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cambrex Corporation
Bora Pharmaceutical CDMO
Piramal Pharma Solutions
Contract Pharmaceuticals Limited
Lubrizol Life Science
Ascendia Pharmaceuticals
PCI Pharma Services
Pierre Fabre Group
DPT Laboratories LTD.
MedPharm Ltd.
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
88 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Topical Drugs CDMO Market Size by Player
- 4 Topical Drugs CDMO by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Topical Drugs CDMO Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
